Ledger.Open graph →
SEC Form D · filed September 9, 2022

Arsenal Biosciences, Inc

Offering
$33.0M
Sold
$33.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SOUTH SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Margaret Nibbi · South San Francisco, CAExecBeth Seidenberg · South San Francisco, CADirectorBrook Byers · South San Francisco, CADirectorMatthew Fust · South San Francisco, CADirectorSean Parker · South San Francisco, CADirectorKenneth Drazan · South San Francisco, CAExec · DirectorMark A. Smith · Old Bethpage, NYDirectorJon C. Northrop · Old Bethpage, NYDirectorSalvatore C. Zizza · Old Bethpage, NYExecEdward A. Schafer · Old Bethpage, NYDirectorJeffrey F. O'Donnell Sr · Malvern, PADirectorWilliam A. Rupp · Old Bethpage, NYExec · DirectorNeeraj B. Hablani · New York, NYDirectorRaghav Mecheri · New York, NYExec · DirectorJames B. Bollas · New York, NYDirectorAlex B. Hartz · New York, NYExecAndrew J. Secrist · Salt Lake City, UTDirectorJennifer L. Norris · Denver, CODirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗